| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 4 | |
| #2 | EPO (European Patent Office) | 2 | |
| #3 | United States | 2 | |
| #4 | Australia | 1 | |
| #5 | Brazil | 1 | |
| #6 | Canada | 1 | |
| #7 | China | 1 | |
| #8 | Israel | 1 | |
| #9 | Republic of Korea | 1 | |
| #10 | Mexico | 1 | |
| #11 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Medical technology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Medical purpose containers |
| # | Name | Total Patents |
|---|---|---|
| #1 | Thiry Michel | 8 |
| #2 | Mariau Jérémie | 6 |
| #3 | Klatzmann David | 5 |
| #4 | Lorenzon Roberta | 4 |
| #5 | Cacoub Patrice | 3 |
| #6 | Mariau Jeremie | 3 |
| #7 | Rosenzwajg Michèle | 3 |
| #8 | Mekinian Arsène | 3 |
| #9 | Michel Thiry | 2 |
| #10 | Jérémie Mariau | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020035482A1 | Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof | |
| WO2020007937A1 | Use of interleukin-2 for treating systemic sclerosis | |
| EP3752178A1 | Use of interleukin 2 for treating sjögren's syndrome | |
| KR20180064536A | The pharmaceutical composition of IL-2 |